Incidence and clinical consequence of the purple glove syndrome in patients receiving intravenous phenytoin

Terence J. O'Brien; Gregory D. Cascino; Elson L. So; Debra R. Hanna

doi:10.1212/WNL.53.7.1611

Incidence and clinical consequence of the purple glove syndrome in patients receiving intravenous phenytoin

Terence J. O'Brien
, Gregory D. Cascino
, Elson L. So
, Debra R. Hanna

Nursing

Mayo Clinic

Research & Scholarship: Contribution to journal › Article › peer-review

Original language	American English
Journal	Neurology
Volume	51
DOIs	https://doi.org/10.1212/WNL.53.7.1611
State	Published - Oct 1 1998

Disciplines

Anesthesiology
Medicine and Health Sciences

Access to Document

10.1212/WNL.53.7.1611

Cite this

@article{84a44fb5607e47a7b77442b84d2befee,

title = "Incidence and clinical consequence of the purple glove syndrome in patients receiving intravenous phenytoin",

author = "O'Brien, \{Terence J.\} and Cascino, \{Gregory D.\} and So, \{Elson L.\} and Hanna, \{Debra R.\}",

note = "To the Editor: We read with interest the retrospective evaluation of purple glove syndrome (PGS) in patients receiving intravenous phenytoin (PHT) by O'Brien et al.1 and the accompanying editorial in the same issue.2 We agree that PGS can be a serious adverse event (AE) related to IV PHT administration, and its incidence may well be under-reported.",

year = "1998",

month = oct,

day = "1",

doi = "10.1212/WNL.53.7.1611",

language = "American English",

volume = "51",

journal = "Neurology",

}

TY - JOUR

T1 - Incidence and clinical consequence of the purple glove syndrome in patients receiving intravenous phenytoin

AU - O'Brien, Terence J.

AU - Cascino, Gregory D.

AU - So, Elson L.

AU - Hanna, Debra R.

N1 - To the Editor: We read with interest the retrospective evaluation of purple glove syndrome (PGS) in patients receiving intravenous phenytoin (PHT) by O'Brien et al.1 and the accompanying editorial in the same issue.2 We agree that PGS can be a serious adverse event (AE) related to IV PHT administration, and its incidence may well be under-reported.

PY - 1998/10/1

Y1 - 1998/10/1

U2 - 10.1212/WNL.53.7.1611

DO - 10.1212/WNL.53.7.1611

M3 - Article

VL - 51

JO - Neurology

JF - Neurology

ER -